32: I Tried to Eat 6% of My Diet From Saturated Fat for a Week and This Is What Happened Part 1

Episode 32: I Tried to Eat 6% of My Diet From Saturated Fat for a Week and This Is What Happened Part 1

I tried to follow the American Heart Association’s saturated fat guideline for a week. I failed before I finished lunch on day one. And I did not eat a single thing on their list of high saturated fat foods.

This is Part 1 of a two-part series sitting squarely in the Fuel pillar of the Perimenopause Matrix. Fuel is about how your body uses energy, and for a lot of women in perimenopause, the lipid picture is one of the first places the Fuel pillar starts to signal. In this episode, I get into why that 6% target is harder to hit than anyone tells you, where that number actually came from, and why almost all of the research behind it was done in men.

I also walk through the AHA’s own math using their own recommended foods, look at the two key trials that came closest to the target, and share the part that should make every woman listening genuinely angry: the guidelines telling us to eat a specific way were built on research that did not include us.

Part 2 drops next week with the full data comparison and my personal experiment results.

“The Mediterranean diet, cited by many of the same voices promoting the 6% guideline as the gold standard of heart-healthy eating, is not clocking in anywhere close to 6% saturated fat. That is not a small contradiction. That is the entire argument.”

What You’ll Learn

  • Why LDL-c and ApoB are not the same thing, and which one is a better predictor of cardiovascular risk for the 20% of people where they diverge
  • What the AHA’s 6% saturated fat target is actually based on, and why the guidelines themselves acknowledge the key studies did not isolate the effect of saturated fat
  • How olive oil, walnuts, and salmon put you over the 6% limit before you finish your first meal
  • Why the RISSCI-1 trial, the cleanest controlled study on saturated fat and LDL, enrolled zero women and produced a response range from a 54-point drop to a 30-point rise in the same group
  • How the Women’s Health Initiative, the only large-scale dietary trial in postmenopausal women, moved LDL by 3.55 points over 8 years with no significant cardiovascular benefit

Key Takeaways

✅ The 6% saturated fat target was not derived from a trial that isolated saturated fat as a single variable. It came from whole dietary pattern studies conducted in metabolic wards where all food was provided.

✅ The PREDIMED study, the most cited evidence for the Mediterranean diet, included roughly 3.5 tablespoons of olive oil per day. That is 7 grams of saturated fat from olive oil alone, before anything else on the plate.

✅ Almost every foundational trial behind the saturated fat guidelines was conducted in men or did not report sex-disaggregated results. We do not have strong data on how the 6% target performs in the female body.

✅ The GET-READI trial, one of the only studies to hit 6% and include a female majority, found that reducing saturated fat lowered LDL but raised Lp(a), an independent cardiovascular risk factor.

✅ Ask your provider about ApoB at your next lipid panel. It tells a more complete story than LDL-c alone, particularly if you are in the 20% where the two markers diverge.


Ready to Understand What’s Actually Going On in Your Body?

If you’re tired of feeling confused about your symptoms and dismissed by doctors who say “everything’s normal,” my Perimenopause Matrix Lab Review is for you.

I’ll analyze your recent labs through the lens of perimenopause and create a personalized roadmap showing you exactly which pillar of the Matrix to focus on first. No more guessing. No more trying to optimize everything at once. Just clear answers and one actionable next step.

Learn more about the Matrix Lab Review →

Download my free Perimenopause Symptom Decoder and get clarity on what’s happening in your body. This guide helps you identify the subtle (and not-so-subtle) signs of perimenopause and understand which symptoms matter most.

You’re not crazy. You’re not broken. You’re not alone. And you absolutely deserve to feel like yourself again.

Related Episodes

Resources

Full Transcript

WELCOME AND THE PERSONAL STAKES

Good morning and welcome back to Mornings with Megan. I’m Megan Pfiffner, CNS and Perimenopause Nutrition Expert, and this is Part 1 of a two-part series on saturated fat. The title of this episode was the cliffhanger. I tried to eat 6% of my diet from saturated fat for a week, and this is what happened.

I’m going to tell you right now: I failed before I finished lunch on day one without eating a single thing on the American Heart Association’s list of high saturated fat foods. Let’s get into it.

Heart disease is the number one killer of women in the United States. Not breast cancer. Heart disease. And in perimenopause, as our estrogen drops, we catch up to men in cardiovascular risk at a speed that should make all of us sit up and pay attention.

So when my LDL came back elevated, I took it seriously. Here is the personal wrinkle: I am in perimenopause and on a fertility journey. As many of you know, Freddie and I are in the process of IVF, and statins are contraindicated for pregnancy. That takes one of the biggest pharmaceutical levers completely off the table for me right now. This isn’t a new finding. It has been creeping up for years. And since I’m doing so much work to prepare my body for pregnancy, I wanted to explore every avenue.


LDL-C VERSUS APOB: WHAT YOUR LIPID PANEL IS ACTUALLY TELLING YOU

Before I go any further, I want to spend a minute on the markers themselves, because this matters for everything we are going to talk about today. And if you have not listened to Episode 16 on lab testing, go back and do that after this one. I go deep on all of that there.

Most standard lipid panels give you LDL-c. The c stands for calculated, meaning it is an estimate derived from a formula, not a direct measurement. There is a more precise and more clinically meaningful marker called ApoB, Apolipoprotein B. Understanding the difference between them changes how you read everything we are going to talk about later.

Here is the plain-language version. Think of LDL particles as delivery trucks carrying cholesterol throughout the bloodstream. LDL-c measures the total amount of cargo across all the trucks combined. ApoB counts the number of trucks. Those two numbers usually move together, but not always. And when they diverge, the truck count, the ApoB, is the better predictor of cardiovascular risk.

Why does the count matter more than the cargo? Because the damage to your arteries happens when individual particles get into the artery walls and set off an inflammatory response. That is a numbers game. The more particles you have circulating, the more chances one has to get somewhere it should not be. It is not about how much cholesterol is in your blood overall. It is about how many particles are on the road.

For roughly 80% of people, LDL-c and ApoB track very closely together. If you are in that group, all of the LDL research we are going to walk through today is directly relevant to you and this is not an issue. For the other 20%, they diverge. The dangerous version is high ApoB with a normal LDL-c: you have a lot of particles in circulation that your standard panel is completely missing. LDL-c still matters because most guidelines and most research are built around it. But if you can access ApoB testing and work with someone who can interpret it, it gives you a much fuller picture. I will link Episode 16 in the show notes.

I do not currently have an ApoB result to share. The nurse practitioner I have been seeing was not comfortable interpreting it, which is completely reasonable, and fertility is our first priority right now. So I am working with a standard lipid panel, and I want you to have that context as we go.


THE EXPERIMENT: DAY ONE

So now let me tell you about my week. Or more accurately, my day.

The American Heart Association recommends keeping saturated fat to 6% or less of your total daily calories as part of a heart-healthy diet and as a tool for lowering LDL. Sounds completely reasonable on paper. So let’s look at what it actually looks like on the plate.

I get between 1,800 and 2,200 calories a day, so I used 2,000 as my average. 6% of 2,000 calories is 120 calories from saturated fat. That works out to about 12 grams. 12 grams. For context, that is less than a tablespoon of butter. That is your entire daily budget.

I started my challenge on a Monday without a ton of prep, just a plan to eat the foods that are not associated with saturated fats or are not considered high saturated fat foods. The American Heart Association lists the high saturated fat foods to avoid as: beef, lamb, pork, poultry with skin, beef fat, tallow, lard, cream, butter, cheese, ice cream, coconut, palm oil, palm kernel oil, and some baked and fried goods.

Here is what I actually ate that day. My coffee with collagen. My black bean brownies, which are made with avocado oil, eggs, black beans, raw cocoa powder, allulose, vanilla, and a bit of maple syrup. Four scrambled eggs cooked in olive oil. Green beans. Romaine lettuce and chicory root. Cherry tomatoes. One tablespoon of Trader Joe’s ranch. Half a pear. And my square of dark chocolate.

I did not have a single thing on the American Heart Association’s list of high saturated fat foods. And I still failed before I even got to my chocolate.

If you have a friend in your head right now who has been told to cut saturated fat and has been white-knuckling it, send her this episode right now. Not when it is over. Right now. Because what comes next is going to make her feel a whole lot better about her life choices.


WHY THE MATH FALLS APART: OLIVE OIL, PREDIMED, AND THE AHA’S OWN RECOMMENDATIONS

Why is this so daunting? What most people do not realize is that foods are made of multiple components. Olive oil is not just monounsaturated fat. One tablespoon has 10 grams of monounsaturated fat, 1.5 grams of polyunsaturated fat, and 2 grams of saturated fat. That makes olive oil a lower saturated fat food, but not a zero saturated fat food.

And here is where it gets really interesting. The PREDIMED study is one of the most cited pieces of evidence supporting the Mediterranean diet for cardiovascular health. It showed a 30% reduction in major cardiovascular events compared to a low-fat diet. The Mediterranean diet group in that study was consuming roughly 3.5 tablespoons of extra-virgin olive oil per day. Three and a half tablespoons of olive oil has about 7 grams of saturated fat. Before anything else goes on the plate. From olive oil alone.

The Mediterranean diet, cited by many of the same voices promoting the 6% guideline as the gold standard of heart-healthy eating, is not clocking in anywhere close to 6% saturated fat. That is not a small contradiction. That is the entire argument.

Let’s walk through the American Heart Association’s own recommendations to see how fast the math falls apart. The AHA says I should replace meat with beans, legumes, fish, and nuts, and cook with liquid vegetable oil rather than tropical oils. Let’s start with nuts since the AHA puts them on the approved list of protein sources. I will gently note that nuts are not actually a great source of protein, but let’s follow the logic.

Half a cup of walnuts has 3.5 grams of saturated fat, almost a third of my daily limit of 12 grams, and it delivers 8 grams of protein. I still need 22 more grams to hit my minimum goal of 30 grams per meal. Half a cup of salmon gets me there at about 22 grams of protein. Farm-raised is 3.5 grams of saturated fat. I am on a budget, so we are going farm-raised. I have now hit 30 grams of protein. I am sitting at 7 grams of saturated fat, and I have not cooked my fish yet.

One tablespoon of olive oil to cook adds another 2 grams of saturated fat. I am now at 9 grams of saturated fat and I have not added a single item from the restricted list. I have not made it past my first meal. To say this is unattainable without someone else preparing every meal you eat is an understatement. And that detail matters enormously for the research, which I am about to get into.


WHERE THE 6% NUMBER ACTUALLY CAME FROM

Here is where the story gets really interesting. I went looking for the study that actually produced the 6% number. What I found should be in every cardiology grand rounds in the country.

The controlled feeding studies that achieved 6% saturated fat were run under metabolic ward conditions, meaning professionals made all of the food for the participants. They also simultaneously changed multiple variables: increasing fiber, increasing fruits and vegetables, increasing minerals like magnesium and potassium. There is no way to know if the 6% saturated fat specifically moved the dial, or if it was the fiber, the potassium, or the overall dietary shift.

Here is the part that really floored me. The 2013 joint guidelines from the American Heart Association and the American College of Cardiology on Lifestyle Management, the document that produced the 6% target, state in their own rationale that these studies do not isolate the effect of saturated fat on LDL-c lowering. They said it themselves. In the footnotes of the very document that told hundreds of millions of people to hit a specific saturated fat percentage.

The two studies cited were the DASH trial and the DELTA trial. Both started participants at 14 to 15% saturated fat and brought them down to between 5 and 6%, a drop of nearly 10 percentage points, across a completely overhauled dietary pattern with all food provided. LDL-c dropped 11 to 13 milligrams per deciliter. That number is the entire foundation of the 6% recommendation, and it came from a total dietary overhaul under conditions most of us will never experience, not from adjusting one variable.


THE TWO KEY TRIALS: RISSCI-1 AND GET-READI

Now let’s look at two other key trials, because this is where the individual story gets important.

The RISSCI-1 trial used a controlled feeding design in men, lowering saturated fat from about 19% to about 9% of total energy while keeping calories and fat constant. The mean LDL-c fell by about 19 milligrams per deciliter, which is a real and meaningful result. But the individual responses ranged from a drop of 54 milligrams per deciliter all the way to a rise, and that is right, a rise, of 30 milligrams per deciliter. About a third of that variation was explained by factors the researchers could measure, like starting LDL levels and how much each person actually reduced their saturated fat intake. The rest was not accounted for by what they were able to track, which tells us there is a lot of individual biology at play. Every single participant in the RISSCI-1 trial was male. We have no data from this study on how women respond to the same change.

The GET-READI trial is one of the few trials to actually reach the American Heart Association’s 6% saturated fat target. Participants followed a DASH-type diet, a broader shift in eating pattern that brought saturated fat down to 6% of total calories, compared to a typical American diet at around 16% saturated fat. LDL-c dropped by 12 milligrams per deciliter, which is a meaningful result. But at the same time, Lp(a) rose significantly in the same participants on the same diet.

Lp(a) is an independent cardiovascular risk marker, meaning it adds to your risk on top of LDL and is notoriously difficult to move with diet and lifestyle under most circumstances. I want to be precise about who was in this study. GET-READI enrolled 166 African American adults, a population in whom elevated Lp(a) is more common, so this finding is not automatically universal. But similar Lp(a) increases have been reported in other dietary intervention studies, which suggests the GET-READI result is not an outlier.

What makes this trial particularly relevant for this conversation is that 70% of the participants were women, making it one of the very few trials in this entire space with meaningful female representation. The study that included the most women, hit the actual 6% target, and represents the population at highest Lp(a) risk is also the one where reducing saturated fat improved one risk marker while raising another. That is not a reason to dismiss the LDL finding. It is simply a reason to want the full picture, not just one number.


WHO WAS ACTUALLY IN THESE STUDIES: THE SEX DATA

Now here is the part that should make every woman listening stop what she is doing. Let’s look at who was actually in all of these studies. And to do that I want to bring you back and tell you how we got here, because this story is worth knowing.

In the 1950s and 60s, a physiologist named Ancel Keys developed what became known as the Diet-Heart Hypothesis: the idea that saturated fat raises cholesterol and that raised cholesterol causes heart disease. His landmark research was called the Seven Countries Study. It examined 12,763 middle-aged men across 16 cohorts in seven countries, looking at saturated fat intake and heart disease rates, and found a correlation. This study became the scientific foundation for decades of dietary guidance, including the guidance we are talking about today.

Nina Teicholz spent nine years researching and documenting this history in her book The Big Fat Surprise, and I want to recommend it genuinely and wholeheartedly. It is a remarkable piece of investigative work that follows the threads of how saturated fat became the dietary villain, who shaped those recommendations, and what the research actually showed. If you want to understand how we got here, that book is the place to go.

One of the things Teicholz surfaces is the question of how the Diet-Heart Hypothesis was shaped in its early days. In 1953, before the Seven Countries Study formally began, Keys published a graph comparing fat intake and heart disease rates in six countries. Data from 16 countries was available at the time, and when you include all of them, the relationship is considerably less clean. France is the most discussed example: relatively high saturated fat consumption alongside lower cardiovascular disease risk than the correlation would predict. Keys acknowledged France as an outlier in his own data but did not pursue the finding with any depth. The French paradox, as it has become known, became one of the most debated questions in nutrition science for decades.

I want to be precise here because this is contested territory. The formal Seven Countries Study and that early 1953 graph were different projects, but the early graph shaped the scientific conversation, and France remained an inconvenient data point that was noted rather than explained. The honest summary is that the foundation of the Diet-Heart Hypothesis was built on an observational study of men only, and some of the most challenging counterexamples were set aside rather than incorporated.

I think Nina Teicholz and Gary Taubes did genuinely important work in exposing the weaknesses in the foundational research. Where I think the conversation has sometimes overcorrected is in treating saturated fat as completely irrelevant to cardiovascular health. The individual sensitivity data, the mechanistic research, and the signal in more rigorous trials suggest the honest answer is more nuanced than either extreme claims. We will get into that in Part 2. But on the origin story of these guidelines, the questions are fair and they deserve to be asked.

Now back to the studies and who was actually in them.

The Seven Countries Study: 12,763 participants across 16 cohorts. All men. Zero women.

The RISSCI-1 controlled feeding trial: 109 participants, all men aged 30 to 65. Zero women.

The DASH and DELTA trials, the two studies cited directly in the 2013 guidelines as the basis for the 6% recommendation: mixed-sex populations, but sex-specific results were not a primary outcome in either study, and we do not have clear data on whether women responded the same way as men.

GET-READI, the trial that hit the 6% target: 166 African American adults, 70% women. The trial with the strongest female representation is also the one where the intervention raised a separate cardiovascular risk marker.

And the Women’s Health Initiative, the only large-scale trial designed specifically for postmenopausal women: 49,000 women, 8 years, full dietary fat intervention. LDL dropped 3.55 milligrams per deciliter on average, with no significant effect on cardiovascular disease, stroke, or coronary heart disease.

The guidelines telling you, a perimenopausal woman, to eat less than 6% of your calories from saturated fat are built primarily on research conducted in men. The one women-specific mega-trial produced the smallest effect of any intervention we have discussed. We do not have good data on how reducing saturated fat, particularly to the 6% level, performs specifically in the female body. That is what the research record shows.


THE MASAI: AN ILLUSTRATION, NOT A PRESCRIPTION

I want to leave you with one more observation before we pick this up in Part 2.

If saturated fat were truly the cardiovascular smoking gun the guidelines suggest, we would expect populations who eat traditional diets very high in saturated fat to show high rates of heart disease. The Masai of Tanzania and the Samburu of Kenya traditionally ate almost exclusively animal fat from milk and meat, with fat making up a very large portion of their calories, between 60 and 80%. When researchers surveyed them in the 1960s, they found low levels of serum cholesterol and very little clinical evidence of cardiovascular disease, despite the high animal fat intake.

I want to be honest about what this observation does and does not show. These were field surveys, not clinical trials. The researchers themselves noted that other factors, including high levels of physical activity and a very different food environment, may have been protective. This is an illustration, not a prescription. But it does raise a legitimate question: if the relationship between saturated fat and heart disease were as straightforward as the guidelines suggest, we would expect to see it show up consistently across populations. The fact that it does not appear in some of these traditional contexts is worth sitting with.

In Part 2 we are going to get into what the research actually shows about moving your lipid numbers, a direct comparison of the tools available to you, and what I found when I ran my own experiment. We are also going to get into the Fuel pillar of the Perimenopause Matrix, because this is exactly where this all lives. I will see you next week.

Still Curious? Dive in here